About
Angelin is a London-based, New York-qualified associate. Her practice primarily focuses on representing issuers, sponsors and underwriters in connection with equity and debt capital markets transactions. She also advises clients on a range of U.S. SEC reporting obligations.
Connect
VCARD
Additional Information
Angelin’s experiences include advising:
- Zabka and CVC Capital Partners on the IPO of Zabka on the Warsaw Stock Exchange;
- Sanofi on the separation and spin-off of Opella, its consumer healthcare business;
- AstraZeneca on the harmonisation of its listing structure in the U.S., the U.K. and Sweden;
- Ferguson Enterprises Inc. on its U.S. redomiciliation;
- Ashtead Group on its U.S. redomiciliation and NYSE listing;
- UBS on its acquisition of Credit Suisse;
- Transnet on its issue of US$1,000,000,000 8.250 per cent. notes due 2028 under its US$6,000,000,000 Global Medium Term Note Programme;
- Aston Martin Lagonda on its £654 million strategic placing and rights issue.
Angelin Oey
Associate
London Office
100 Bishopsgate
London EC2P 2SR